We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Additionally, the calibration procedure had no arrangements for including an evaluation of adverse effects on a device’s quality when testing equipment is found to be out-of-calibration. Read More
The FDA cited devicemakers in Sweden, Germany and China for GMP and other lapses, including inadequate design history files and complaint handling. Read More